Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC) | Norton Healthcare

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Indication: Hepatocellular Carcinoma (HCC)

A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete Radiological Response after Surgical Resection or Local Ablation (KEYNOTE-937)

Sub-indication: Gastrointestinal Cancer

Study Type: Drug Study

Principal Investigator: Robert Martin, M.D., Ph.D.
University of Louisville Physicians - Surgical Oncology

Sponsor: Sponsor: Merck Sharp & Dohme CORP

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Hepatocellular Carcinoma (HCC) Clinical Trial

Schedule an Appointment